157 related articles for article (PubMed ID: 33545254)
1. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis.
Spampinato S; Fokdal LU; Pötter R; Haie-Meder C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van der Steen-Banasik E; Van Limbergen E; Sundset M; Westerveld H; Nout RA; Jensen NBK; Kirisits C; Kirchheiner K; Tanderup K;
Radiother Oncol; 2021 May; 158():312-320. PubMed ID: 33545254
[TBL] [Abstract][Full Text] [Related]
2. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis.
Spampinato S; Fokdal LU; Pötter R; Haie-Meder C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van der Steen-Banasik E; Van Limbergen E; Sundset M; Westerveld H; Nout RA; Jensen NBK; Kirisits C; Kirchheiner K; Tanderup K;
Radiother Oncol; 2021 May; 158():300-308. PubMed ID: 33065183
[TBL] [Abstract][Full Text] [Related]
3. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
[TBL] [Abstract][Full Text] [Related]
4. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
K Jensen NB; Pötter R; Spampinato S; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Van der Steen-Banasik E; Van Limbergen E; Sundset M; Pieters BR; Nout RA; Kirisits C; Kirchheiner K; Tanderup K;
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):688-700. PubMed ID: 33068689
[TBL] [Abstract][Full Text] [Related]
5. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato S; Jensen NBK; Pötter R; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Hoskin P; Segedin B; Rai B; Bruheim K; Wiebe E; Van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Lutgens LCHW; Tan LT; Villafranca E; Smet S; Jastaniyah N; Nout RA; Kirisits C; Chopra S; Kirchheiner K; Tanderup K; Embrace Collaborative Group
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):681-693. PubMed ID: 34678431
[TBL] [Abstract][Full Text] [Related]
6. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
7. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study.
Vittrup AS; Tanderup K; Bentzen SM; Jensen NBK; Spampinato S; Fokdal LU; Lindegaard JC; Sturdza A; Schmid M; Segedin B; Jürgenliemk-Schulz IM; Bruheim K; Mahantshetty U; Haie-Meder C; Rai B; Cooper R; van der Steen-Banasik E; Sundset M; Huang F; Nout RA; Villafranca E; Van Limbergen E; Pieters BR; Tan LT; Lutgens LCHW; Hoskin P; Pötter R; Kirchheiner K;
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):161-173. PubMed ID: 32853710
[TBL] [Abstract][Full Text] [Related]
9. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
10. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
Najjari Jamal D; Pötter R; Haie-Meder C; Lindegaard JC; Juergenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Tanderup K; Kirchheiner K;
Radiother Oncol; 2018 Jun; 127(3):449-455. PubMed ID: 29631933
[TBL] [Abstract][Full Text] [Related]
11. Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques.
Seppenwoolde Y; Majercakova K; Buschmann M; Dörr E; Sturdza AE; Schmid MP; Pötter R; Georg D
Strahlenther Onkol; 2021 Jun; 197(6):505-519. PubMed ID: 33929558
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C;
J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120
[TBL] [Abstract][Full Text] [Related]
14. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Vittrup AS; Kirchheiner K; Pötter R; Fokdal LU; Jensen NBK; Spampinato S; Haie-Meder C; Schmid MP; Sturdza AE; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Wiebe E; van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Kirisits C; Lindegaard JC; Jürgenliemk-Schulz IM; Nout R; Tanderup K;
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):807-824. PubMed ID: 36641039
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
16. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
Manea E; Escande A; Bockel S; Khettab M; Dumas I; Lazarescu I; Fumagalli I; Morice P; Deutsch E; Haie-Meder C; Chargari C
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):411-420. PubMed ID: 29559282
[TBL] [Abstract][Full Text] [Related]
17. The effect of lower urinary tract substructure doses on side effects of cervical cancer image-guided adaptive brachytherapy.
Azak C; Kavak G; Ertan F; Alioğlu F; Akkaş EA; Göksel F; Karakaya E
J Cancer Res Ther; 2023 Oct; 19(7):1825-1830. PubMed ID: 38376285
[TBL] [Abstract][Full Text] [Related]
18. Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer.
Georg P; Boni A; Ghabuous A; Goldner G; Schmid MP; Georg D; Pötter R; Dörr W
Strahlenther Onkol; 2013 Jul; 189(7):535-40. PubMed ID: 23703404
[TBL] [Abstract][Full Text] [Related]
19. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
20. Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
Smet S; Pötter R; Haie-Meder C; Lindegaard JC; Schulz-Juergenliemk I; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van Limbergen E; Tanderup K; Kirchheiner K;
Radiother Oncol; 2018 Jun; 127(3):440-448. PubMed ID: 29627137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
